bioRxiv Science⌕ Search

Biology subjects

Navarro-Pando, J. M.

Publications and source records attributed to Navarro-Pando, J. M..

3 recordsLinked to original sources

Supraphysiological Estradiol During Ovarian Stimulation Reveals Microbiome Resilience and Prevotella Opportunism

How the oral ecosystem responds to acute, high-amplitude hormonal perturbations remains poorly defined. Here we exploit controlled ovarian hyperstimulation (COH), a pharmacologically defined model that elevates systemic estradiol (E2) [~]100-fold above physiological baseline to dissect the multi-layer response of the oral environment in ten healthy oocyte donors. Integrating paired serum and salivary hormone quantification with subgingival metatranscriptomics, we identify a dual principle governing the oral ecosystem under acute endocrine stress. First, salivary E2 reliably tracks intra-individual systemic dynamics, confirmed by robust linear regression, establishing saliva as a non-invasive endocrine proxy even under supraphysiological conditions. Second, despite the dramatic hormonal surge, the subgingival metatranscriptome exhibited functional resilience with no differentially expressed genes detected across two independent bioinformatic pipelines while a core of 20,687 genes remained stably expressed at both timepoints, underscoring the robustness of established biofilm communities. This global stability was selectively broken by four Prevotella species, whose abundance increased proportionally to salivary E2 elevation, consistent with their steroid hormone auxotrophy. Together, these findings reveal that the subgingival microbiome is functionally buffered against acute hormonal perturbation yet harbors estrogen-sensitive taxa capable of exploiting endocrine surges as ecological opportunities, with potential implications for reproductive and systemic inflammatory health.

microbiology↗

NLRP3 inflammasome inhibition rescues Hutchinson-Gilford Progeria cellular phenotype and extend longevity of an animal model

Inflammation is a hallmark of aging and accelerated aging syndromes. In this context, inflammation has been associated to the pathophysiology of Hutchinson-Gilford progeria syndrome (HGPS). In this study, we report that progeroid skin fibroblasts and animal models present an hyperactivation of the NLRP3-inflammasome complex. High expression of NLRP3 and caspase 1 was also observed in skin fibroblasts from HGPS associated to the nuclei morphology. Lymphoblast from HGPS also showed increased basal levels of NLRP3 and caspase 1 independent to the induction from metabolic factors. Consistent with these results, Zmpste24-/- showed high expression of Nlrp3 and caspase 1 in heart, liver and kidney and reduced levels of Nlrc3, however these changes were not observed in other inflammasomes. We also show that pharmacological inhibition of NLRP3 using a direct NLRP3 inhibitor, MCC950, improved cellular phenotype, significantly extends the lifespan of these progeroid animals and reduced inflammasome-dependent inflammation. These findings suggest the NLRP3-inflammasome comples as a therapeutic approach for patients with HGPS.

immunology↗

Inhibition of the NLRP3 inflammasome prevents ovarian aging

Inflammation is a hallmark of many processes during aging and reproductive physiology, negatively affecting female fertility. The goal of this study was to evaluate the role of the NLRP3 inflammasome in ovarian aging and female fertility. Age-dependent increased expression of NLRP3 in the ovary was observed in female WT mice during reproductive aging. High expression of NLRP3, caspase 1 and IL-1{beta} was also observed in granulosa cells from patients with primary ovarian insufficiency. Ablation of the NLRP3 inflammasome improved the survival and pregnancy rates in mice, increased hormonal levels of AMH, a biochemical marker of ovarian reserve, and autophagy rates in ovarian tissue. Deficiency of the NLRP3 inflammasome also reduced serum FSH and estradiol levels. Consistent with these results, pharmacological inhibition of NLRP3 using a direct NLRP3 inhibitor, MCC950, improved fertility in female mice to levels comparable to those of Nlrp3-/- mice. These results suggest that the NLRP3 inflammasome is implicated in the age-dependent loss of female fertility and position this inflammasome as a potential new therapeutic target for the treatment of infertility.

immunology↗